Compliance with antihypertensive therapy among elderly medicaid enrolles : The roles of age, gender, and race.
This study measured compliance and related demographic factors in a retrospective cohort of 4068 elderly outpatients newly starting antihypertensive therapy from 1982 through 1988.
Logistic regression modeling of data from the New Jersey Medicaid program was used.
These patients filled antihypertensive prescriptions covering an average of only 179 days in the 365-day follow-up period (49%). Good compliance (=80%) was associated with advanced age (odds ratio [OR]=2.12, for patients 85 or older) and White race (OR=0.55 for Blacks), There was no relationship between compliance and gender.
Despite the efficacy of antihypertensive therapy in preventing cardiovascular morbidity, such high rates of noncompliance may contribute to suboptimal patient outcomes.
Mots-clés Pascal : Antihypertenseur, Observance médicamenteuse, Vieillard, Homme, Ambulatoire, Epidémiologie, Facteur risque, Age, Sexe, Race, Chimiothérapie, Traitement, New Jersey, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Antihypertensive agent, Drug compliance, Elderly, Human, Ambulatory, Epidemiology, Risk factor, Age, Sex, Race, Chemotherapy, Treatment, New Jersey, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0154173
Code Inist : 002B02F05. Création : 21/05/1997.